Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Adriaan A van Beek"'
Autor:
Jie Wei, Shahram Salek-Ardakani, Wenjing Yang, Lucia Campos Carrascosa, Adriaan A van Beek, Valeska de Ruiter, Michail Doukas, Timothy S Fisher, Keith Ching, Karlijn van Loon, Patrick P C Boor, Yannick S Rakké, Lisanne Noordam, Pascal Doornebosch, Dirk Grünhagen, Kees Verhoef, Wojciech G Polak, Jan N M IJzermans, Irene Ni, Yik Andy Yeung, Dave Sprengers, Jaap Kwekkeboom
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background OX40 (CD134) is a costimulatory molecule of the tumor necrosis factor receptor superfamily that is currently being investigated as a target for cancer immunotherapy. However, despite promising results in murine tumor models, the clinical e
Externí odkaz:
https://doaj.org/article/e56e3eb9973e485888dbd8bd5af2b0dc
Autor:
Adriaan A Van Beek, Bruno Sovran, Floor Hugenholtz, Ben Meijer, Joanne Hoogerland, Violeta Mihailova, Corine van der Ploeg, Clara Belzer, Mark V Boekschoten, Jan JH Hoeijmakers, Wilbert P Vermeij, Paul De Vos, Jerry M Wells, Pieter JM Leenen, Claudio Nicoletti, Rudi W Hendriks, Huub FJ Savelkoul
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Although it is clear that probiotics improve intestinal barrier function, little is known about the effects of probiotics on the aging intestine. We investigated effects of 10-wk bacterial supplementation of Lactobacillus plantarum WCFS1, Lactobacill
Externí odkaz:
https://doaj.org/article/089a5bce46ee410bb166763dc679f0a9
Autor:
Melanie de Gier, Ingrid Pico-Knijnenburg, Monique M. van Ostaijen-ten Dam, Dagmar Berghuis, Frans J. Smiers, Adriaan A. van Beek, Hetty Jolink, Patty M. Jansen, Arjan C. Lankester, Mirjam van der Burg
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for various hematological, immunological and metabolic diseases, replacing the patient’s hematopoietic system with donor-derived healthy hematopoietic stem cells. HSC
Externí odkaz:
https://doaj.org/article/43cc956a59494f48bfa1c4c189550255
Autor:
Benthe van der Lugt, Adriaan A. van Beek, Steven Aalvink, Ben Meijer, Bruno Sovran, Wilbert P. Vermeij, Renata M. C. Brandt, Willem M. de Vos, Huub F. J. Savelkoul, Wilma T. Steegenga, Clara Belzer
Publikováno v:
Immunity & Ageing, Vol 16, Iss 1, Pp 1-17 (2019)
Abstract Background The use of Akkermansia muciniphila as potential therapeutic intervention is receiving increasing attention. Health benefits attributed to this bacterium include an improvement of metabolic disorders and exerting anti-inflammatory
Externí odkaz:
https://doaj.org/article/2009f81821734aafbf450b1122f78a11
Autor:
Adriaan A. van Beek, Floris Fransen, Ben Meijer, Paul de Vos, Edward F. Knol, Huub F. J. Savelkoul
Publikováno v:
Immunity & Ageing, Vol 15, Iss 1, Pp 1-11 (2018)
Abstract Background The influence of age on basophils is poorly understood, as well as the effect of aging-associated microbiota on basophils. Therefore, we studied the influence of aging and aging-associated microbiota on basophil frequency and phen
Externí odkaz:
https://doaj.org/article/ccd14a573eb448138d6ec74f07f889dd
Autor:
Guoying Zhou, Lisanne Noordam, Dave Sprengers, Michail Doukas, Patrick P. C. Boor, Adriaan A. van Beek, Remco Erkens, Shanta Mancham, Dirk Grünhagen, Anand G. Menon, Johan F. Lange, Pim J. W. A. Burger, Alexandra Brandt, Boris Galjart, Cornelis Verhoef, Jaap Kwekkeboom, Marco J. Bruno
Publikováno v:
OncoImmunology, Vol 7, Iss 7 (2018)
Purpose: Liver metastasis develops in >50% of patients with colorectal cancer (CRC), and is a leading cause of CRC-related mortality. We aimed to identify which inhibitory immune checkpoint pathways can be targeted to enhance functionality of intra-t
Externí odkaz:
https://doaj.org/article/860f7b5822ba4d95acd8859e33f3e7a5
Autor:
Floris Fransen, Adriaan A. van Beek, Theo Borghuis, Sahar El Aidy, Floor Hugenholtz, Christa van der Gaast – de Jongh, Huub F. J. Savelkoul, Marien I. De Jonge, Mark V. Boekschoten, Hauke Smidt, Marijke M. Faas, Paul de Vos
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Advanced age is associated with chronic low-grade inflammation, which is usually referred to as inflammaging. Elderly are also known to have an altered gut microbiota composition. However, whether inflammaging is a cause or consequence of an altered
Externí odkaz:
https://doaj.org/article/4b89781d37d84a47976bbb1f8cf57c7c
Autor:
Floris Fransen, Adriaan A. van Beek, Theo Borghuis, Ben Meijer, Floor Hugenholtz, Christa van der Gaast-de Jongh, Huub F. Savelkoul, Marien I. de Jonge, Marijke M. Faas, Mark V. Boekschoten, Hauke Smidt, Sahar El Aidy, Paul de Vos
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Males and females are known to have gender-specific differences in their immune system and gut microbiota composition. Whether these differences in gut microbiota composition are a cause or consequence of differences in the immune system is not known
Externí odkaz:
https://doaj.org/article/7a28dc18453d4c6c88fff233769d4cec
Autor:
Yannick S. Rakké, Lucia Campos Carrascosa, Adriaan A. van Beek, Valeska de Ruiter, Rachelle S. van Gemerden, Michail Doukas, Pascal G. Doornebosch, Maarten Vermaas, Susan ter Borg, Erwin van der Harst, Peter Paul L.O. Coene, Mike Kliffen, Dirk J. Grünhagen, Cornelis Verhoef, Jan N.M. IJzermans, Jaap Kwekkeboom, Dave Sprengers
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, 15(1), 77-97. Elsevier Inc.
BACKGROUND & AIMS: In contrast to mismatch repair deficient colorectal carcinoma (CRC), MMR proficient (pMMR) CRC does not respond to immune checkpoint blockade. We studied immune checkpoint stimulation via glucocorticoid-induced tumor necrosis facto
Autor:
Timothy Scott Fisher, Lucia Campos Carrascosa, Valeska de Ruiter, Yannick S. Rakké, Yik Andy Yeung, Pascal Doornebosch, Jie Wei, Jan N. M. IJzermans, Kees Verhoef, Michail Doukas, Karlijn van Loon, Shahram Salek-Ardakani, Wenjing Yang, Keith A. Ching, Lisanne Noordam, Wojciech G. Polak, Patrick P.C. Boor, Dave Sprengers, Irene Ni, Jaap Kwekkeboom, Dirk J. Grünhagen, Adriaan A. van Beek
Publikováno v:
Journal for ImmunoTherapy of Cancer, 8(2):000816. BioMed Central Ltd.
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
BackgroundOX40 (CD134) is a costimulatory molecule of the tumor necrosis factor receptor superfamily that is currently being investigated as a target for cancer immunotherapy. However, despite promising results in murine tumor models, the clinical ef